<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>LA062690-0161</title>
	</head>
	<body>
		<main>
			<p><P> June 26, 1990, Tuesday, P.M. Final  </P> <P> P.M. BRIEFING;  </P> <P> DU PONT TO MARKET SOVIET DRUG  </P> <P> The Du Pont Co. announced today that it has received government approval to  market the first Soviet drug licensed and clinically developed by an American  pharmaceutical company.  </P> <P> The company said the Food and Drug Administration agreed to permit the use of  Ethmozine for the treatment of abnormal and life-threatening heart rhythms  known as ventricular arrhythmias.  </P> <P> These irregular heartbeats are caused by heart attack, coronary artery blockage  and other disorders and are blamed for hundreds of thousands of deaths each  year.  </P> <P> Dr. John Mullane, director of drug development for Du Pont, said the drug was  discovered in the late 1960s in Moscow and has been available in the Soviet  Union for about 18 years.  </P></p>
		</main>
</body></html>
            